GSK plc - 23 Jan 2023 Form 3 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
10%+ Owner
Signature
Victoria Whyte, Authorized Signatory, GSK plc
Issuer symbol
WVE
Transactions as of
23 Jan 2023
Net transactions value
$0
Form type
3
Filing time
30 Jan 2023, 15:34:24 UTC
Previous filing
14 Nov 2022
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WVE Ordinary Shares 10,683,761 23 Jan 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").